Patents by Inventor Paul Maes

Paul Maes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND PREVENTION OF PULMONARY DISEASES
    Publication number: 20230218515
    Abstract: The present invention relates to a golf ball-like microparticles obtained by atomization of nanosuspensions of nanoparticles or solutions for dry powder inhalers for use in the treatment and prevention of pulmonary diseases.
    Type: Application
    Filed: September 10, 2020
    Publication date: July 13, 2023
    Inventors: PAUL MAES, DIDIER CATALDO, WILLIAM BIGAZZI, BRIGITTE EVRARD
  • INHALABLE COMPOSITION COMPROMISING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NASAL INFLAMMATIONS
    Publication number: 20220249540
    Abstract: The present invention relates to an inhalable composition comprising cyclodextrin for the treatment of nasal inflammations. In a preferred embodiment, the treatment is topical.
    Type: Application
    Filed: June 30, 2020
    Publication date: August 11, 2022
    Inventors: DIDIER CATALDO, MARIE-ASTRID ALBERT, PAUL MAES
  • Use of a photosynthetic cell extract comprising functional thylakoids in cosmetic compositions
    Patent number: 10653615
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: May 19, 2020
    Inventors: Andre P. Boulet, Paul Maes
  • Use of a Photosynthetic Cell Extract Comprising Functional Thylakoids In Cosmetic Compositions
    Publication number: 20180325802
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Application
    Filed: July 9, 2018
    Publication date: November 15, 2018
    Inventors: Andre P. BOULET, Paul MAES
  • Use of a photosynthetic cell extract comprising functional thylakoids in cosmetic compositions
    Patent number: 10045934
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: August 14, 2018
    Assignee: Groupe Sante Devonian
    Inventors: Andre P. Boulet, Paul Maes
  • Cyclodextrin and budesonide derivative compositions and methods
    Patent number: 9993487
    Abstract: The present invention relates to novel and useful pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and/or prevention of pulmonary inflammatory disease. The present invention also relates to a novel and useful analytical technique for the detection and the quantification of HP-?-CD in solution. More specifically, the present invention relates to the use of a validated 1H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without any extraction or separation steps for liquid formulations.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: June 12, 2018
    Inventors: Didier Cataldo, Brigitte Evrard, Gilles Dufour, Pascal de Tullio, Paul Maes
  • Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
    Patent number: 9757388
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 12, 2017
    Assignee: Acerus Pharmaceuticals SRL
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • Modified release formulations of a bupropion salt
    Patent number: 9504640
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: November 29, 2016
    Assignee: Valeant Pharmaceuticals Luxembourg S.Á.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • CYCLODEXTRIN AND BUDESONIDE DERIVATIVE COMPOSITIONS AND METHODS
    Publication number: 20160051568
    Abstract: The present invention relates to novel and useful pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and/or prevention of pulmonary inflammatory disease. The present invention also relates to a novel and useful analytical technique for the detection and the quantification of HP-?-CD in solution. More specifically, the present invention relates to the use of a validated 1H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without any extraction or separation steps for liquid formulations.
    Type: Application
    Filed: March 30, 2015
    Publication date: February 25, 2016
    Inventors: Didier Cataldo, Brigitte Evrard, Gilles Dufour, Pascal de Tullio, Paul Maes
  • Modified Release Formulations Of A Bupropion Salt
    Publication number: 20150202147
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 23, 2015
    Applicant: VALEANT INTERNATIONAL BERMUDA
    Inventors: Werner OBEREGGER, Fang ZHOU, Paul MAES, Stefano TURCHETTA, Graham JACKSON, Pietro MASSARDO, Mohammad Ashty SALEH
  • Controlled Release Dosage Forms
    Publication number: 20150030675
    Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.
    Type: Application
    Filed: April 25, 2014
    Publication date: January 29, 2015
    Applicant: Valeant International Bermuda
    Inventors: Fang ZHOU, Paul MAES
  • Modified release formulations of a bupropion salt
    Patent number: 8932628
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: January 13, 2015
    Assignee: Valeant International Bermuda
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • THE USE OF A PHOTOSYNTHETIC CELL EXTRACT COMPRISING FUNCTIONAL THYLAKOIDS IN COSMETIC COMPOSITIONS
    Publication number: 20130309181
    Abstract: The invention relates to cosmetic and topical compositions containing an effective amount of a photosynthetic cell extract comprising a functional thylakoid system. The cosmetic compositions have anti-wrinkle and anti-aging effects on a user's skin. In addition, the photosynthetic cell extract protects skin against ultraviolet A (UVA) and ultraviolet (UVB) damage.
    Type: Application
    Filed: April 12, 2011
    Publication date: November 21, 2013
    Inventors: Andre P. Boulet, Paul Maes
  • BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
    Publication number: 20130266650
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 10, 2013
    Inventors: Graham JACKSON, Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • CONTROLLED RELEASE DOSAGE FORMS
    Publication number: 20130245154
    Abstract: The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.
    Type: Application
    Filed: May 13, 2013
    Publication date: September 19, 2013
    Inventors: Fang ZHOU, Paul Maes
  • INTRANASAL 0.6% AND 0.72% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130059827
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: March 7, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.15% AND 0.24% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130045958
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 21, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.45% AND 0.48% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130040922
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 14, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL LOWER DOSAGE STRENGTH TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130040923
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 14, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • Modified-release formulations of a bupropion salt
    Patent number: 7884136
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: February 8, 2011
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh